Regulators of type-1tumor necrosis factor receptor and other cytokine receptor shedding
AssigneeThe United States of America as represented by the Department of Health and Human Services
InventorStewart Levine
Life of this patent
Estimating the term…
Abstract
The present invention provides compositions and methods for the regulation of cytokine signaling through the Tumor Necrosis Factor (TNF) pathway. Specifically, the invention provides a novel gene, polypeptide and related compositions and methods for the regulation of ectodomain shedding. In preferred embodiments, methods and compositions for the regulation of TNF Type-1 Receptor ectodomain shedding are provided. The present invention finds use in therapeutics, diagnostics, and drug screening applications.
Claims49
An isolated nucleic acid having the nucleotide sequence set forth in SEQ ID NO:1.
An isolated polypeptide having the amino acid sequence set forth in SEQ ID NO:2.
An isolated nucleic acid encoding the polypeptide set forth in SEQ ID NO:2.
A method for regulating the shedding of the extracellular domain of at least one cytokine receptor, comprising the steps of:
- a) providing:
- i) a polypeptide having the amino acid sequence set forth in SEQ ID NO:2, and
- ii) a tissue comprising one or more cells expressing a cytokine receptor on their plasma membrane extracellular surface;
- and
- b) delivering said polypeptide to said tissue under conditions such that said polypeptide regulates the shedding of the cytokine receptor from the surface of said cells of said tissue.
A method for drug screening to identify drugs capable of regulating the peptidase activity of ARTS-1, comprising the steps of:
- a) providing:
- i) purified ARTS-1 polypeptide,
- ii) an amino acid p-nitroaniline,
- iii) a means to measure amino acid p-nitroaniline cleavage, and
- iv) a drug;
- b) exposing said purified ARTS-1 polypeptide to said amino acid p-nitroaniline in the absence and presence of said drug;
- and
- c) measuring amino acid p-nitroaniline cleavage in the absence and presence of said drug.
A method for drug screening to identify drugs capable of regulating the shedding of a cytokine receptor, comprising the steps of:
- a) providing:
- i) cultured cells expressing a cytokine receptor,
- ii) a means to quantitate the concentration of the soluble form of said cytokine receptor in the supernatants of said cultured cells, and
- iii) a drug;
- b) culturing said cells in the absence and presence of said drug;
- c) quantitating the concentration of said soluble form of said cytokine receptor in said supernatants of said cultured cells using said means;
- and
- d) comparing the concentrations of said soluble cytokine receptor in said supernatants of said cell cultures in the absence and presence of drug.
Dependencies are inferred from the claim text.